XML 23 R12.htm IDEA: XBRL DOCUMENT v3.20.1
Inventory
3 Months Ended
Mar. 31, 2020
Inventory Disclosure [Abstract]  
Inventory Inventory
The Company evaluates expiry risk by evaluating current and future product demand relative to product shelf life. The Company builds demand forecasts by considering factors such as, but not limited to, overall market potential, market share, market acceptance and patient usage. Inventory levels are evaluated for the amount of inventory that would be sold within one year. At certain times, the level of inventory can exceed the forecasted level of cost of goods sold for the next twelve months. The Company classifies the estimate of such inventory as non-current.
Inventory consisted of the following as of March 31, 2020 and December 31, 2019:

(in thousands)
March 31,
2020
 
December 31,
2019
Current assets
 
 
 
Finished goods
$
1,320

 
$
1,140

Total inventory, current
$
1,320

 
$
1,140

Non-Current assets
 
 
 
Raw materials
$
659

 
$
659

Work-in-process
949

 
1,109

Finished goods
934

 
1,056

Total inventory, non-current
2,542

 
2,824

Total inventory
$
3,862

 
$
3,964